Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1745 - 1752 of 11454 results
How USPTO Pharma Reform Could Lower Counsel Spend
July 15, 2022| News
Rule 11 Sanctions Appropriate for Frivolous Inventorship Pleading
July 13, 2022| Blog| Viewpoint
SCOTUS Declines to Answer Calls for Clarification in American Axle v. Neapco
July 13, 2022| Blog| Viewpoint
Post-Dobbs Abortion-Related Travel Benefits: Surveying Employers’ Options
July 13, 2022| Blog| Viewpoint
FDA’s Review of Pulse Oximeter Performance Continues a Trend in Addressing Biases in Digital Health Technologies
July 12, 2022| Blog| Viewpoint
Stress-Testing A Real Estate JV Ahead Of New Challenges
July 12, 2022| News
Real Estate Joint Ventures: Stress-Testing New Challenges
July 12, 2022| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.